PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION. World Bulletin of Public Health, [S. l.], v. 56, p. 82–84, 2026. Disponível em: https://scholarexpress.net/index.php/wbph/article/view/5983. Acesso em: 4 jun. 2026.